Taking semaglutide for weight loss and diabetes, which sells under popular brand names Ozempic and Wegovy, may be linked to an increased risk of developing an eye condition that can lead to vision loss and blindness, according to a study published last week in JAMA Ophthalmology.
Compared to…
[ad_2]
Source link
